NASDAQ:ICCM
IceCure Medical Ltd
- Stock
Last Close
1.02
17/05 20:00
Market Cap
52.41M
Beta: 1.38
Volume Today
136.48K
Avg: 172.94K
PE Ratio
−4.11
PFCF: −3.75
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 307.00K - | 320.88K 4.52% | 309.94K 3.41% | 476.78K 53.83% | 685.26K 43.73% | 929.80K 35.69% | 1.55M 66.56% | 2.41M 55.36% | 2.57M 6.65% | |||
average payables | 108.26K - | 106.45K 1.67% | 138.64K 30.23% | 302.73K 118.36% | 439.32K 45.12% | 535.17K 21.82% | 762.84K 42.54% | 797.50K 4.54% | 608K 23.76% | |||
average receivables | -413.32K - | -251.13K 39.24% | -250.18K 0.38% | -545.58K 118.08% | -423.43K 22.39% | 385.50K - | 1.04M 170.95% | 773K 25.99% | ||||
book value per share | 1.39 - | 1.18 15.36% | 0.40 66.32% | -0.04 110.35% | 0.29 802.00% | 0.19 33.08% | 0.94 - | 0.69 27.27% | ||||
capex per share | -0.14 - | -0.03 81.15% | -0.00 92.77% | -0.00 129.46% | -0.00 68.05% | -0.01 298.81% | -0.01 36.49% | -0.02 - | -0.02 28.93% | |||
capex to depreciation | -0.62 - | -0.30 50.91% | -0.10 67.97% | -0.42 333.65% | -0.26 38.87% | -2.09 706.67% | -0.66 68.46% | -0.89 35.82% | -4.20 369.61% | -3.59 14.39% | -1.49 58.64% | |
capex to operating cash flow | 0.02 - | 0.01 58.89% | 0.00 81.94% | 0.01 298.11% | 0.00 54.99% | 0.02 537.77% | 0.06 179.83% | 0.06 9.04% | 0.04 33.92% | 0.06 47.43% | 0.04 38.51% | |
capex to revenue | -0.24 - | -0.03 86.70% | -0.01 74.97% | -0.04 353.84% | -0.01 65.77% | -0.06 378.76% | -0.06 2.88% | -0.06 5.56% | -0.13 121.14% | -0.29 124.23% | -0.15 48.53% | |
cash per share | 1.97 - | 1.38 29.77% | 0.53 61.55% | 0.23 56.19% | 0.36 54.15% | 0.42 18.21% | 0.90 - | 0.64 28.78% | ||||
days of inventory on hand | 153.86 - | 241.92 57.24% | 288.66 19.32% | 213.12 26.17% | 382.57 79.51% | 242.16 36.70% | 292.33 20.72% | 367.25 25.63% | 635.86 73.14% | 430.47 32.30% | ||
days payables outstanding | 67.72 - | 66.15 2.31% | 112.74 70.42% | 108.19 4.03% | 265.31 145.22% | 143.70 45.84% | 164.99 14.82% | 165.50 0.31% | 158.91 3.98% | 94.99 40.23% | ||
days sales outstanding | -198.26 - | -117.80 40.58% | -149.42 26.84% | -129.35 13.43% | -288.37 122.93% | 68.01 - | 155.94 129.30% | 25.77 83.47% | ||||
debt to assets | 0.48 - | 0.03 - | 0.03 13.08% | 0.03 3.31% | 0.02 29.77% | 0.04 84.58% | ||||||
debt to equity | -3.64 - | 0.09 - | 0.07 29.64% | 0.03 48.67% | 0.02 30.36% | 0.05 109.71% | ||||||
dividend yield | ||||||||||||
earnings yield | -0.19 - | -0.08 56.84% | -0.03 67.84% | -0.01 45.53% | -0.01 17.49% | -0.01 39.29% | -0.01 25.68% | -0.12 - | -0.30 159.57% | |||
enterprise value | 53.50M - | 134.32M 151.07% | 219.36M 63.31% | 236.26M 7.71% | 475.08M 101.08% | 508.12M 6.96% | -3.20M 100.63% | 62.36M 2,048.37% | 34.31M 44.98% | -9.93M 128.95% | ||
enterprise value over ebitda | -13.40 - | -39.13 191.93% | -72.30 84.79% | -85.90 18.81% | -138.83 61.61% | -109.70 20.99% | 0.74 100.67% | -6.50 980.57% | -2.08 67.98% | 0.65 131.30% | ||
ev to operating cash flow | -15.80 - | -40.09 153.83% | -70.05 74.72% | -90.01 28.49% | -155.06 72.27% | -291.70 88.12% | 0.86 100.30% | -4.95 674.68% | -2.40 51.47% | 0.79 133.05% | ||
ev to sales | 50.07 - | 176.07 251.68% | 350.70 99.18% | 342.72 2.27% | 443.21 29.32% | 306.54 30.84% | -0.78 100.26% | 15.07 2,023.19% | 11.12 26.19% | -3.08 127.66% | ||
free cash flow per share | -5.72 - | -2.59 54.79% | -1.03 60.28% | -0.60 42.05% | -0.42 29.30% | -0.27 36.37% | -0.14 49.42% | -0.46 - | -0.41 10.87% | |||
free cash flow yield | -0.15 - | -0.06 59.75% | -0.02 60.36% | -0.01 41.27% | -0.01 21.66% | -0.01 41.32% | -0.00 44.99% | -0.15 - | -0.26 75.38% | |||
graham net net | 0.64 - | 1.01 56.66% | 0.30 70.51% | -0.12 141.08% | 0.17 240.09% | 0.11 37.93% | 0.77 - | 0.58 24.80% | ||||
graham number | 10.56 - | 5.52 47.77% | 2.35 57.45% | 0.65 72.24% | 1.40 114.98% | 1.23 12.06% | 2.74 - | 2.68 2.05% | ||||
income quality | 0.76 - | 0.72 5.38% | 0.89 24.28% | 0.96 7.24% | 0.91 4.68% | 0.87 5.02% | 0.36 57.91% | 0.79 117.23% | 1.27 60.71% | 0.84 33.92% | 0.85 1.52% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -8.06 - | -45.85 - | -49.96 8.96% | -202.01 304.36% | -137.50 31.93% | -70.04 - | ||||||
interest debt per share | 0.16 - | 0.01 96.58% | 0.02 262.31% | 0.03 - | 0.02 29.07% | |||||||
inventory turnover | 2.37 - | 1.51 36.40% | 1.26 16.19% | 1.71 35.45% | 0.95 44.29% | 1.51 57.98% | 1.25 17.16% | 0.99 20.40% | 0.57 42.24% | 0.85 47.71% | ||
invested capital | -3.64 - | 0.09 - | 0.07 29.64% | 0.03 48.67% | 0.02 30.36% | 0.05 109.71% | ||||||
market cap | 23.50M - | 56.10M 138.78% | 138.84M 147.47% | 222.17M 60.02% | 236.78M 6.58% | 479.27M 102.41% | 513.65M 7.17% | 87.07M - | 57.38M 34.11% | |||
net current asset value | 1.63M - | 3.72M 128.01% | 2.02M 45.84% | -331.74K 116.45% | 3.27M 1,084.31% | 2.21M 32.36% | 3.92M 77.70% | 25.00M 536.97% | 23.36M 6.54% | 9.94M 57.47% | ||
net debt to ebitda | 0.65 - | 1.32 101.68% | 0.93 29.45% | 0.19 79.59% | 1.23 546.80% | 1.19 2.53% | 0.74 38.22% | 2.57 248.94% | 1.40 45.69% | 0.65 53.43% | ||
net income per share | -7.35 - | -3.56 51.53% | -1.15 67.77% | -0.62 46.25% | -0.46 25.54% | -0.30 34.16% | -0.35 15.56% | -0.35 - | -0.47 31.91% | |||
operating cash flow per share | -5.58 - | -2.56 54.14% | -1.02 59.95% | -0.59 42.36% | -0.42 29.02% | -0.26 37.47% | -0.13 51.22% | -0.44 - | -0.39 12.55% | |||
payables turnover | 5.39 - | 5.52 2.36% | 3.24 41.32% | 3.37 4.20% | 1.38 59.22% | 2.54 84.63% | 2.21 12.90% | 2.21 0.31% | 2.30 4.15% | 3.84 67.29% | ||
receivables turnover | -1.84 - | -3.10 68.30% | -2.44 21.16% | -2.82 15.51% | -1.27 55.14% | 5.37 - | 2.34 56.39% | 14.16 505.05% | ||||
research and ddevelopement to revenue | 2.39 - | 0.94 60.54% | 1.29 36.52% | 2.66 106.91% | 2.17 18.31% | 1.81 16.68% | 1.72 5.13% | 1.00 41.86% | 1.42 42.22% | 2.96 108.22% | 2.56 13.36% | |
return on tangible assets | -1.43 - | -0.74 47.92% | -0.99 32.92% | -1.49 50.85% | -0.67 54.83% | -0.65 3.28% | -0.46 28.96% | -0.31 32.52% | -0.57 82.90% | -0.89 56.55% | ||
revenue per share | 0.57 - | 0.81 41.73% | 0.23 71.09% | 0.12 49.44% | 0.11 6.68% | 0.09 16.70% | 0.12 32.67% | 0.14 - | 0.08 42.50% | |||
roe | -2.56 - | -0.97 61.93% | -1.56 59.58% | 11.19 819.75% | -1.05 109.38% | -1.81 72.68% | -1.04 42.50% | -0.37 64.18% | -0.68 81.38% | -1.20 77.87% | ||
roic | -1.38 - | -0.77 44.26% | -1.27 65.52% | -3.05 140.28% | -0.64 79.00% | -1.47 130.30% | -0.86 41.90% | -0.34 59.88% | -0.64 85.52% | -1.17 82.79% | ||
sales general and administrative to revenue | 3.27 - | 1.22 62.84% | 1.76 44.39% | 1.51 14.05% | 1.48 1.77% | 0.99 32.95% | 0.79 20.05% | 0.43 45.81% | 1.00 131.44% | 1.90 90.45% | 2.29 20.58% | |
shareholders equity per share | 1.39 - | 1.18 15.36% | 0.40 66.32% | -0.04 110.35% | 0.29 802.00% | 0.19 33.08% | 0.94 - | 0.69 27.27% | ||||
stock based compensation to revenue | 0.35 - | 0.47 36.12% | 0.48 0.68% | 0.02 95.04% | 0.17 606.44% | 0.20 16.93% | 0.22 12.08% | 0.06 73.93% | 0.08 33.55% | 0.60 691.64% | 0.41 32.89% | |
tangible asset value | 1.84M - | 3.85M 109.04% | 2.10M 45.38% | -256.93K 112.22% | 3.37M 1,410.37% | 2.63M 22.00% | 4.58M 74.51% | 26.96M 488.21% | 25.42M 5.70% | 12.16M 52.16% | ||
tangible book value per share | 1.39 - | 1.18 15.36% | 0.40 66.32% | -0.04 110.35% | 0.29 802.00% | 0.19 33.08% | 0.94 - | 0.69 27.27% | ||||
working capital | 2.32M - | 4.27M 84.19% | 2.67M 37.57% | 289.45K 89.15% | 3.99M 1,277.10% | 3.27M 17.89% | 5.77M 76.28% | 26.30M 355.86% | 23.79M 9.54% | 10.31M 56.66% |
All numbers in USD (except ratios and percentages)